Literature DB >> 24390934

The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke.

Jianfeng Ge1, Ling Guo, Shan Wang, Yiling Zhang, Ting Cai, Robert C H Zhao, Yaojiong Wu.   

Abstract

BACKGROUND AND
PURPOSE: Intravascular injection of mesenchymal stem cells (MSCs) has been found to cause considerable vascular obstructions which may lead to serious outcomes, particularly after intra-arterial injection. However, the underlying mechanisms have been poorly understood.
METHODS: In this study, we fractionated MSCs that had been cultured in monolayer for six passages into small (average diameter = 17.9 μm) and large (average diameter 30.4 μm) populations according to their sizes, and examined their vascular obstructions after intra-internal carotid artery injection in rats and mice in comparison with MSCs derived from 3D spheroids which were uniformly smaller in size (average diameter 12.6 μm).
RESULTS: We found that 3D MSCs did not cause detectable infarct in the brain as evidenced by MRI scan and TTC stain, 2D MSCs in small size caused a microinfarct in one of five animals, which was co-localized to the area of entrapped MSCs (labeled with DiI), while 2D MSCs in large size caused much larger infarcts in all five animals, and substantial amounts of DiI-positive MSCs were found in the infarct. Meanwhile, corresponding neurological defects were observed in the animals with stroke. In consistence, injection of 2D MSCs (average diameter 26.5) caused a marked loss of cortical neurons and their axons in Thy1-GFP transgenic mice and the activation of microglia in CX3CR1-GFP transgenic mice in the area with MSC entrapment.
CONCLUSIONS: Our results suggest that the size of MSCs is a significant cause of MSC caused vascular obstructions and stroke.

Entities:  

Mesh:

Year:  2014        PMID: 24390934     DOI: 10.1007/s12015-013-9492-x

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  33 in total

1.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect.

Authors:  Uwe M Fischer; Matthew T Harting; Fernando Jimenez; Werner O Monzon-Posadas; Hasen Xue; Sean I Savitz; Glen A Laine; Charles S Cox
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

Review 2.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Visualization of gene expression in whole mouse retina by in situ hybridization.

Authors:  Michael B Powner; Kristis Vevis; Jenny A G McKenzie; Pranita Gandhi; Shalini Jadeja; Marcus Fruttiger
Journal:  Nat Protoc       Date:  2012-05-10       Impact factor: 13.491

Review 4.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

5.  Treatment of stroke in rat with intracarotid administration of marrow stromal cells.

Authors:  Y Li; J Chen; L Wang; M Lu; M Chopp
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.

Authors:  Cindy T J van Velthoven; R Ann Sheldon; Annemieke Kavelaars; Nikita Derugin; Zinaida S Vexler; Hanneke L D M Willemen; Mirjam Maas; Cobi J Heijnen; Donna M Ferriero
Journal:  Stroke       Date:  2013-03-28       Impact factor: 7.914

8.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

Authors:  Ryang Hwa Lee; Andrey A Pulin; Min Jeong Seo; Daniel J Kota; Joni Ylostalo; Benjamin L Larson; Laura Semprun-Prieto; Patrice Delafontaine; Darwin J Prockop
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

Review 9.  Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.

Authors:  Mark A Eckert; Quynh Vu; Kate Xie; Jingxia Yu; Wenbin Liao; Steven C Cramer; Weian Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-06-12       Impact factor: 6.200

10.  Intravenous mesenchymal stem cell therapy for traumatic brain injury.

Authors:  Matthew T Harting; Fernando Jimenez; Hasan Xue; Uwe M Fischer; James Baumgartner; Pramod K Dash; Charles S Cox
Journal:  J Neurosurg       Date:  2009-06       Impact factor: 5.115

View more
  65 in total

1.  Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment.

Authors:  Xuegang Yuan; Jens T Rosenberg; Yijun Liu; Samuel C Grant; Teng Ma
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

2.  Adhesion, distribution, and migration of differentiated and undifferentiated mesenchymal stem cells (MSCs) seeded on nerve allografts.

Authors:  Femke Mathot; Nadia Rbia; Allen T Bishop; Steven E R Hovius; Andre J Van Wijnen; Alexander Y Shin
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-05-22       Impact factor: 2.740

3.  Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits.

Authors:  Sonia Labrador Velandia; Salvatore Di Lauro; Maria Luz Alonso-Alonso; Soraya Tabera Bartolomé; Girish Kumar Srivastava; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-22       Impact factor: 3.117

Review 4.  Targeted stimulation of MSCs in peripheral nerve repair.

Authors:  Femke Mathot; Alexander Y Shin; Andre J Van Wijnen
Journal:  Gene       Date:  2019-03-05       Impact factor: 3.688

Review 5.  Intra-Arterial Delivery of Cell Therapies for Stroke.

Authors:  Raphael Guzman; Miroslaw Janowski; Piotr Walczak
Journal:  Stroke       Date:  2018-04-18       Impact factor: 7.914

6.  Triggered micropore-forming bioprinting of porous viscoelastic hydrogels.

Authors:  Guangyu Bao; Tao Jiang; Hossein Ravanbakhsh; Alicia Reyes; Zhenwei Ma; Mitchell Strong; Huijie Wang; Joseph M Kinsella; Jianyu Li; Luc Mongeau
Journal:  Mater Horiz       Date:  2020-07-16       Impact factor: 13.266

7.  Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model.

Authors:  Hamed Ghazavi; Seyed Javad Hoseini; Alireza Ebrahimzadeh-Bideskan; Baratali Mashkani; Soghra Mehri; Ahmad Ghorbani; Kayvan Sadri; Elahe Mahdipour; Faezeh Ghasemi; Fatemeh Forouzanfar; Azar Hoseini; Ali Reza Pasdar; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 8.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 9.  Macrophage-based cell therapies: The long and winding road.

Authors:  Simon Lee; Saul Kivimäe; Aaron Dolor; Francis C Szoka
Journal:  J Control Release       Date:  2016-07-12       Impact factor: 9.776

10.  Human adipose-derived stromal vascular fraction: characterization, safety and therapeutic potential in an experimental mouse model of articular injury.

Authors:  Jordan A Dykstra; Elliot D Blue; Pedro L Negrão de Assis; Jill M Weimer; Daniel Jiro Kota
Journal:  J Stem Cells Regen Med       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.